ARCA biopharma, Inc. (ABIO)
How ABIO actually reacts to news — the realized, point-in-time move the market made, measured across 100 labeled events over the last three years with zero look-ahead.
ABIO’s median reaction, across the day.
Half of all ARCA biopharma, Inc. news events land between -0.65% and +1.86% at 30 minutes.
Reaction stats as of 2026-08-13. Reaction = percent move vs. the price at the news timestamp.
Email me when ABIO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ABIO’s baseline. Nothing else.
Get “How ABIO reacts to news” as a PDF.
A free one-page summary: ABIO’s median reaction to news and the full breakdown by event type — the numbers on this page, in one page.
Recent ABIO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Oruka Therapeutics, Inc. For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K Oruka Therapeutics, Inc. For: Aug 29 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split | Press release | GlobeNewswire | -1.28% | +2.13% | |
| Form 8-K ARCA biopharma, Inc. For: Aug 26 | SEC filing · Form 8-K | SEC EDGAR | +0.14% | +2.38% | |
| Form SEC STAFF LETTER ARCA biopharma, Inc. | SEC filing · Form SEC | SEC EDGAR | — | +3.12% | |
| ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics | Press release | GlobeNewswire | +0.14% | +2.38% | |
| ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics | Press release | GlobeNewswire | -4.56% | -3.54% | |
| Form 8-K ARCA biopharma, Inc. For: Aug 22 | SEC filing · Form 8-K | SEC EDGAR | -4.56% | -3.54% | |
| ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics | Press release | GlobeNewswire | +5.84% | +16.23% | |
| Form 8-K ARCA biopharma, Inc. For: Aug 16 | SEC filing · Form 8-K | SEC EDGAR | +5.84% | +16.23% | |
| Form 8-K ARCA biopharma, Inc. For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.87% | |
| ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | -1.16% | +3.32% | |
| Form 10-Q ARCA biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.16% | +3.32% | |
| Form 8-K ARCA biopharma, Inc. For: Aug 01 | SEC filing · Form 8-K | SEC EDGAR | -1.16% | +3.32% | |
| Form EFFECT ARCA biopharma, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +1.45% | -0.97% | |
| Form ARS ARCA biopharma, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +1.45% | -0.97% | |
| Form S-4/A ARCA biopharma, Inc. | SEC filing · Form S-4 | SEC EDGAR | +0.00% | -4.29% | |
| Form 8-K ARCA biopharma, Inc. For: Jul 03 | SEC filing · Form 8-K | SEC EDGAR | -1.09% | -2.83% | |
| Form S-4/A ARCA biopharma, Inc. | SEC filing · Form S-4 | SEC EDGAR | -1.09% | -2.83% | |
| Form S-4/A ARCA biopharma, Inc. | SEC filing · Form S-4 | SEC EDGAR | +0.00% | -0.61% | |
| SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate ABIO, MODN, DPSI, AIRC | Press release | PR Newswire | +0.72% | -4.33% | |
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, HIBB, ABIO, HMNF | Press release | PR Newswire | — | -0.61% | |
| Form S-4 ARCA biopharma, Inc. | SEC filing · Form S-4 | SEC EDGAR | -0.87% | -3.77% | |
| ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | -2.99% | -2.72% | |
| Form 10-Q ARCA biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -2.99% | -2.72% | |
| Form 8-K ARCA biopharma, Inc. For: Apr 25 | SEC filing · Form 8-K | SEC EDGAR | -2.99% | -2.72% | |
| Form 8-K ARCA biopharma, Inc. For: Apr 20 | SEC filing · Form 8-K | SEC EDGAR | +1.10% | -0.28% | |
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO | Press release | PR Newswire | +0.27% | -0.68% | |
| Abio Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arca Biopharma, Inc. Is Fair to Shareholders | Press release | Accesswire | +1.31% | -1.96% | |
| Form 8-K ARCA biopharma, Inc. For: Apr 02 | SEC filing · Form 8-K | SEC EDGAR | +2.70% | +4.39% | |
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA, ABIO | Press release | PR Newswire | +1.31% | +0.66% | |
| ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders | Press release | Business Wire | +9.97% | +11.68% | |
| ARCA biopharma and Oruka Therapeutics Announce Merger Agreement | Press release | GlobeNewswire | +9.97% | +11.68% | |
| Form 8-K ARCA biopharma, Inc. For: Apr 03 | SEC filing · Form 8-K | SEC EDGAR | +9.97% | +11.68% | |
| Form 8-K ARCA biopharma, Inc. For: Mar 19 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.81% | |
| Form 8-K ARCA biopharma, Inc. For: Feb 02 | SEC filing · Form 8-K | SEC EDGAR | +1.26% | +0.63% | |
| ARCA biopharma Announces 2023 Financial Results | Press release | GlobeNewswire | +0.00% | +3.19% | |
| Form 10-K ARCA biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +3.19% | |
| Form 8-K ARCA biopharma, Inc. For: Feb 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.19% | |
| Form 8-K ARCA biopharma, Inc. For: Jan 30 | SEC filing · Form 8-K | SEC EDGAR | +0.63% | -1.26% | |
| Form ARS ARCA biopharma, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.00% | -1.15% | |
| Form DEF 14A ARCA biopharma, Inc. For: Jan 30 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -1.15% | |
| Form DEFA14A ARCA biopharma, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -1.15% | |
| Form 8-K ARCA biopharma, Inc. For: Dec 04 | SEC filing · Form 8-K | SEC EDGAR | — | +1.10% | |
| Form 8-K ARCA biopharma, Inc. For: Nov 29 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.94% | |
| ARCA biopharma Announces Third Quarter 2023 Financial Results | Press release | GlobeNewswire | — | -0.98% | |
| Form 10-Q ARCA biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -0.98% | |
| Form 8-K ARCA biopharma, Inc. For: Oct 18 | SEC filing · Form 8-K | SEC EDGAR | — | -0.98% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ABIO section they belong to.
More of the dataset.
ABIO earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is ARCA biopharma, Inc.'s median reaction calculated?
Every labeled ABIO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 100 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 47% of ABIO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-13.
Does ABIO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.